LEUCOVORIN CALCIUM
FOLIC ACID·FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
BLUEPOINT LABOR
Indication
Adjunct to fluorouracil treatment of colorectal cancer
Colorectal cancer is a malignancy arising from the epithelial lining of the large intestine, encompassing both the colon and the rectum. Read more about Adjunct to fluorouracil treatment of colorectal cancer
32 drugs 25 manufacturers
Drugs that treat it
Common Adjunct to fluorouracil treatment of colorectal cancer therapies.
LEVOLEUCOVORIN CALCIUM
PYRIMETHAMINE TOXICITY·+6
Actavis Pharma
LEUCOVORIN CALCIUM
FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
WEST-WARD,INC.
LEUCOVORIN CALCIUM
FOLIC ACID·FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
Hikma Pharmaceuticals USA
LEUCOVORIN CALCIUM
FOLIC ACID·FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
INGENUS PHARMAC
LEUCOVORIN CALCIUM
FOLIC ACID·FOLIC ACID DEFICIENT MEGALOBLASTIC ANEMIA·+7
FRESENIUS KABI
LEVOLEUCOVORIN CALCIUM
FOLIC ACID·PYRIMETHAMINE TOXICITY·+6
Hikma Pharmaceuticals USA
LEVOLEUCOVORIN CALCIUM
PYRIMETHAMINE TOXICITY·+6
NORTHSTAR RX LL
LEVOLEUCOVORIN CALCIUM
FOLIC ACID·PYRIMETHAMINE TOXICITY·+6
INGENUS PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Adjunct to fluorouracil treatment of colorectal cancer preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonColorectal cancer is a malignancy arising from the epithelial lining of the large intestine, encompassing both the colon and the rectum.
Pathophysiologically, it typically develops through the accumulation of genetic and epigenetic alterations in intestinal mucosa, leading to uncontrolled proliferation, local tissue invasion, and potential lymphatic or distant metastatic spread.
The therapeutic indication "adjunct to fluorouracil treatment of colorectal cancer" refers to a supportive or synergistic systemic intervention administered alongside fluorouracil-based antimetabolite chemotherapy.
This clinical approach is designed to biochemically potentiate fluorouracil cytotoxicity or enhance antitumor efficacy in patients receiving therapy for colorectal adenocarcinoma.
- fda.gov
Colorectal cancer is a malignancy arising from the epithelial lining of the large intestine, encompassing both the colon and the rectum This clinical approach is designed to biochemically potentiate fluorouracil cytotoxicity or enhance antitumor efficacy in patients receiving therapy for colorectal adenocarcinoma
- oncologynewscentral.com
Colorectal cancer is a malignancy arising from the epithelial lining of the large intestine, encompassing both the colon and the rectum Pathophysiologically, it typically develops through the accumulation of genetic and epigenetic alterations in intestinal mucosa, leading to uncontrolled proliferation, local tissue invasion, and potential lymphatic or distant metastatic spread
- drugs.com
The therapeutic indication "adjunct to fluorouracil treatment of colorectal cancer" refers to a supportive or synergistic systemic intervention administered alongside fluorouracil-based antimetabolite chemotherapy This clinical approach is designed to biochemically potentiate fluorouracil cytotoxicity or enhance antitumor efficacy in patients receiving therapy for colorectal adenocarcinoma
- mims.com
The therapeutic indication "adjunct to fluorouracil treatment of colorectal cancer" refers to a supportive or synergistic systemic intervention administered alongside fluorouracil-based antimetabolite chemotherapy This clinical approach is designed to biochemically potentiate fluorouracil cytotoxicity or enhance antitumor efficacy in patients receiving therapy for colorectal adenocarcinoma
Personalize your experience
Follow Adjunct to fluorouracil treatment of colorectal cancer and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.